Immunicum: Dosing proceeds to the next level
Research Note
2019-10-02
09:24
In the ongoing ILIAD combination study, the dose escalation committee has given the thumbs up to move on the next dose level of ilixadencel to 10 million cells (3 million cells in the first cohort n=3).
KP
Klas Palin
Disclosures and disclaimers